TW200633716A - Compositions and methods for stabilizing active pharmaceutical ingredients - Google Patents
Compositions and methods for stabilizing active pharmaceutical ingredientsInfo
- Publication number
- TW200633716A TW200633716A TW094143885A TW94143885A TW200633716A TW 200633716 A TW200633716 A TW 200633716A TW 094143885 A TW094143885 A TW 094143885A TW 94143885 A TW94143885 A TW 94143885A TW 200633716 A TW200633716 A TW 200633716A
- Authority
- TW
- Taiwan
- Prior art keywords
- compositions
- methods
- active pharmaceutical
- pharmaceutical ingredients
- stabilizing active
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/717—Celluloses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Ophthalmology & Optometry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63545004P | 2004-12-13 | 2004-12-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200633716A true TW200633716A (en) | 2006-10-01 |
Family
ID=36129953
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW094143885A TW200633716A (en) | 2004-12-13 | 2005-12-12 | Compositions and methods for stabilizing active pharmaceutical ingredients |
Country Status (15)
Country | Link |
---|---|
US (1) | US20060127473A1 (zh) |
EP (1) | EP1874275A1 (zh) |
JP (1) | JP2008523044A (zh) |
KR (1) | KR20080013847A (zh) |
CN (1) | CN101262852A (zh) |
AR (1) | AR052153A1 (zh) |
AU (1) | AU2005315291A1 (zh) |
BR (1) | BRPI0518553A2 (zh) |
CA (1) | CA2590834A1 (zh) |
MX (1) | MX2007007069A (zh) |
NZ (1) | NZ555909A (zh) |
RU (1) | RU2391115C2 (zh) |
TW (1) | TW200633716A (zh) |
WO (1) | WO2006064327A1 (zh) |
ZA (1) | ZA200705750B (zh) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ588134A (en) * | 2005-06-17 | 2010-11-26 | Aft Pharmaceuticals Ltd | Novel pharmaceutical for use in a method for treatment of upper respiratory mucosal congestion |
WO2007020079A2 (en) * | 2005-08-17 | 2007-02-22 | Synthon B.V. | Orally disintegratable simvastatin tablets |
US8940796B2 (en) | 2006-02-21 | 2015-01-27 | Wyeth Llc | Phenylephrine liquid formulations |
TWI411451B (zh) | 2006-06-01 | 2013-10-11 | Msd Consumer Care Inc | 用於結腸吸收之脫羥腎上腺素醫藥調配物及組合物 |
EP2029114B1 (en) * | 2006-06-01 | 2014-09-24 | Merck Sharp & Dohme Corp. | Pharmaceutical compositions for sustained release of phenylephrine |
AU2007254819A1 (en) * | 2006-06-01 | 2007-12-13 | Schering Corporation | Phenylphrine pulsed release formulations and pharmaceutical compositions |
NZ573174A (en) * | 2006-06-01 | 2012-01-12 | Msd Consumer Care Inc | Sustained release pharmaceutical dosage form containing phenylephrine |
US9005652B2 (en) | 2006-07-25 | 2015-04-14 | Wyeth | Chewable tablet containing phenylephrine |
US20090068262A1 (en) * | 2007-04-04 | 2009-03-12 | Ilan Zalit | Rapid dissolution of combination products |
WO2008150493A1 (en) * | 2007-06-01 | 2008-12-11 | Schering-Plough Healthcare Products, Inc. | Pharmaceutical composition comprising a substrate and a coating containing an active ingredient and polyvinylalcohol |
US8323695B2 (en) * | 2007-08-13 | 2012-12-04 | Mcneil-Ppc, Inc. | Method for stabilizing phenylephrine |
US9078824B2 (en) * | 2007-09-24 | 2015-07-14 | The Procter & Gamble Company | Composition and method of stabilized sensitive ingredient |
PE20091084A1 (es) * | 2007-12-07 | 2009-07-23 | Schering Plough Healthcare | Formulaciones farmaceuticas de fenilefrina y composiciones para absorcion transmucosal |
US20090214665A1 (en) * | 2008-02-26 | 2009-08-27 | Lai Felix S | Controlled Release Muscarinic Receptor Antagonist Formulation |
US8491930B2 (en) * | 2008-04-23 | 2013-07-23 | Farmasierra Manufacturing, S.L. | Pharmaceutical formulation containing ibuprofen and codeine |
US20110189274A1 (en) * | 2008-10-06 | 2011-08-04 | Swati Mukherjee | Stable Pharmaceutical Compositions Of Montelukast Or Its Salts Or Solvates Or Hydrates |
US10130627B2 (en) * | 2008-12-19 | 2018-11-20 | GlaxoSmithKine Consumer Healthcare S.A. | Phenylephrine formulations with improved stability |
EP2379057B1 (en) | 2008-12-19 | 2013-07-17 | Novartis AG | Phenylephrine formulations with improved stability |
US8603527B2 (en) * | 2010-10-25 | 2013-12-10 | Signal Pharmaceuticals, Llc | Pharmaceutical formulations of a substituted diaminopurine |
ITMI20112221A1 (it) * | 2011-12-05 | 2013-06-06 | Altergon Sa | Formulazioni stabili in capsule di gelatina molle di antiaggreganti piastrinici, acidi grassi omega-3 e amilosio |
WO2016090389A1 (en) * | 2014-12-01 | 2016-06-09 | Rathogwa Michael T | Decongestant gum |
US11278506B2 (en) * | 2015-10-09 | 2022-03-22 | Rb Health (Us) Llc | Pharmaceutical formulation |
EP3481379A4 (en) * | 2016-07-05 | 2020-03-11 | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | ORAL GALENIC FORM CONTAINING A QUICK RELEASE EXTERIOR COATING |
CN106727370A (zh) * | 2016-12-07 | 2017-05-31 | 万全万特制药(厦门)有限公司 | 一种含有盐酸齐拉西酮的口崩片及其制备方法 |
WO2018207257A1 (ja) * | 2017-05-09 | 2018-11-15 | 大塚製薬株式会社 | 包装薬剤 |
CN108670811A (zh) * | 2018-05-22 | 2018-10-19 | 河南华冠新能源科技有限公司 | 量子自发热温灸理疗片配方及其制备方法 |
WO2020150460A1 (en) * | 2019-01-18 | 2020-07-23 | Milne Iii Donald A | Micronized aspirin formulation |
CN110279695B (zh) * | 2019-08-07 | 2022-04-08 | 北京博智绿洲医药科技有限公司 | 一种治疗流涕、鼻塞等感冒症状的药物组合物及其制备方法和用途 |
CN111214449B (zh) * | 2020-03-02 | 2021-09-07 | 广东彼迪药业有限公司 | 一种盐酸西替利嗪片剂及其制备方法 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2881113A (en) * | 1957-01-29 | 1959-04-07 | Ortho Pharma Corp | Therapeutically active compositions containing amphetamines |
BE611639A (zh) * | 1960-12-28 | |||
US3352752A (en) * | 1963-07-25 | 1967-11-14 | Tintex Corp | Intestinal adsorbent compositions |
US3337402A (en) * | 1963-09-03 | 1967-08-22 | Hoffmann La Roche | Stable and palatable pharmaceutical composition |
US3337403A (en) * | 1963-09-05 | 1967-08-22 | Hoffmann La Roche | Stable and palatable pharmaceutical compositions |
US3449266A (en) * | 1964-05-25 | 1969-06-10 | Drackett Co | Stabilized solid granular perfume composition |
US3272594A (en) * | 1965-10-22 | 1966-09-13 | Merck & Co Inc | Preparation of magnesium trisilicate |
US3567819A (en) * | 1969-01-30 | 1971-03-02 | Hoffmann La Roche | Cold tablet |
US3636200A (en) * | 1969-06-09 | 1972-01-18 | Hoffmann La Roche | Pharmaceutical suspension |
IL58462A0 (en) * | 1978-10-27 | 1980-01-31 | Beecham Group Ltd | Intramammary compositions comprising a penicillin |
US4327076A (en) * | 1980-11-17 | 1982-04-27 | Life Savers, Inc. | Compressed chewable antacid tablet and method for forming same |
US4327077A (en) * | 1981-05-29 | 1982-04-27 | Life Savers, Inc. | Compressed chewable antacid tablet and method for forming same |
US4581232A (en) * | 1983-07-20 | 1986-04-08 | Warner-Lambert Company | Magnesium trisilicate suitable for preparation of medicament adsorbates |
US4493827A (en) * | 1983-11-14 | 1985-01-15 | Ronald Valle | Method of inducing sleep |
US4910023A (en) * | 1988-06-09 | 1990-03-20 | Warner-Lambert Company | Drug in combination with flavor masking agent and method for making same |
US5585115A (en) * | 1995-01-09 | 1996-12-17 | Edward H. Mendell Co., Inc. | Pharmaceutical excipient having improved compressability |
WO1999063969A1 (en) * | 1998-06-08 | 1999-12-16 | Groenewoud Pieter J | Stabilized thyroxine medications |
US6399101B1 (en) * | 2000-03-30 | 2002-06-04 | Mova Pharmaceutical Corp. | Stable thyroid hormone preparations and method of making same |
SI21221A (sl) * | 2002-06-21 | 2003-12-31 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Hitro razpadljive tablete |
MXPA05005781A (es) * | 2002-11-29 | 2005-12-12 | Forest Laboratories | Combinacion de ibuprofeno y oxicodona para alivio de dolor agudo. |
US20040162273A1 (en) * | 2003-01-23 | 2004-08-19 | The Procter & Gamble Company | Powder pharmaceutical compositions |
US20040265375A1 (en) * | 2003-04-16 | 2004-12-30 | Platteeuw Johannes J. | Orally disintegrating tablets |
-
2005
- 2005-12-01 JP JP2007545012A patent/JP2008523044A/ja not_active Abandoned
- 2005-12-01 EP EP05810183A patent/EP1874275A1/en not_active Withdrawn
- 2005-12-01 BR BRPI0518553-0A patent/BRPI0518553A2/pt not_active IP Right Cessation
- 2005-12-01 RU RU2007126652/15A patent/RU2391115C2/ru not_active IP Right Cessation
- 2005-12-01 MX MX2007007069A patent/MX2007007069A/es not_active Application Discontinuation
- 2005-12-01 AU AU2005315291A patent/AU2005315291A1/en not_active Abandoned
- 2005-12-01 CA CA002590834A patent/CA2590834A1/en not_active Abandoned
- 2005-12-01 CN CNA2005800466509A patent/CN101262852A/zh active Pending
- 2005-12-01 WO PCT/IB2005/003723 patent/WO2006064327A1/en active Application Filing
- 2005-12-01 KR KR1020077015917A patent/KR20080013847A/ko not_active Application Discontinuation
- 2005-12-01 NZ NZ555909A patent/NZ555909A/en not_active IP Right Cessation
- 2005-12-12 TW TW094143885A patent/TW200633716A/zh unknown
- 2005-12-12 AR ARP050105190A patent/AR052153A1/es not_active Application Discontinuation
- 2005-12-13 US US11/301,609 patent/US20060127473A1/en not_active Abandoned
-
2007
- 2007-07-12 ZA ZA200705750A patent/ZA200705750B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
US20060127473A1 (en) | 2006-06-15 |
AR052153A1 (es) | 2007-03-07 |
KR20080013847A (ko) | 2008-02-13 |
NZ555909A (en) | 2009-11-27 |
CA2590834A1 (en) | 2006-06-22 |
CN101262852A (zh) | 2008-09-10 |
WO2006064327A1 (en) | 2006-06-22 |
ZA200705750B (en) | 2008-11-26 |
JP2008523044A (ja) | 2008-07-03 |
RU2391115C2 (ru) | 2010-06-10 |
RU2007126652A (ru) | 2009-01-20 |
BRPI0518553A2 (pt) | 2008-11-25 |
EP1874275A1 (en) | 2008-01-09 |
AU2005315291A1 (en) | 2006-06-22 |
MX2007007069A (es) | 2008-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200633716A (en) | Compositions and methods for stabilizing active pharmaceutical ingredients | |
TW200609001A (en) | Particulate-stabilized injectable pharmaceutical compositions of posaconasole | |
MY143795A (en) | Tetrahydropyridoindole derivatives | |
WO2005112633A3 (en) | Compounds and compositions for delivering active agents | |
MX2009013810A (es) | Uso de homo y copolimeros para la estabilizacion de formulaciones de principios activos. | |
ATE486587T1 (de) | Formulierungen zur oralen verabreichung von wirkstoffen | |
DE602005021770D1 (de) | Indol-1-yl-essigsäurederivate | |
MX2007004281A (es) | Combinaciones de productos activos, funguicidas. | |
MX2007006539A (es) | Sistema para la absorcion percutanea mejorada de los agentes beneficiadores de la piel. | |
TW200731971A (en) | Solid preparation | |
MX2008001917A (es) | Mezclas insecticidas, sinergicas. | |
EA200800698A1 (ru) | Способ стабилизации фармацевтических форм для введения, включающих микроорганизмы | |
CY1113462T1 (el) | Μορφη δοσολογιας περιεχουσα παντοπραζολη ως δραστικο συστατικο | |
TW200738283A (en) | Formulations of conjugated estrogens and bazedoxifene | |
MXPA03007857A (es) | Compuestos y composiciones para entregar agentes activos. | |
TW200621773A (en) | Bicyclononene derivatives | |
MXPA03010054A (es) | Composiciones que comprenden lopinavir y metodos para aumentar la biodisponibilidad de agentes farmaceuticos. | |
WO2005065639A3 (en) | Novel pharmaceutical compositions | |
TW200628468A (en) | Bicyclononene derivatives | |
EA200801614A1 (ru) | Фармацевтическая композиция, содержащая монтелукаст | |
NO20065791L (no) | Asyklovir-formuleringer | |
TW200503785A (en) | Dosage form containing (S)-pantoprazole as active ingredient | |
TW200621774A (en) | Bicyclononene derivatives | |
TW200509794A (en) | Novel anthelmintic and insecticidal compositions | |
TW200531693A (en) | Prolonged-release diuretic compositions |